PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 111 filers reported holding PLIANT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,089,766 | -26.9% | 985,569 | -23.6% | 0.01% | -8.3% |
Q2 2023 | $23,386,614 | -22.0% | 1,290,652 | +14.6% | 0.01% | -29.4% |
Q1 2023 | $29,965,671 | +391.7% | 1,126,529 | +257.3% | 0.02% | +325.0% |
Q4 2022 | $6,094,904 | -5.5% | 315,308 | +2.2% | 0.00% | 0.0% |
Q3 2022 | $6,447,000 | +160.8% | 308,618 | 0.0% | 0.00% | +300.0% |
Q2 2022 | $2,472,000 | +1515.7% | 308,618 | +1316.5% | 0.00% | – |
Q1 2022 | $153,000 | -25.7% | 21,787 | +42.8% | 0.00% | – |
Q4 2021 | $206,000 | -15.9% | 15,261 | +5.4% | 0.00% | – |
Q3 2021 | $245,000 | -43.7% | 14,481 | -3.0% | 0.00% | – |
Q2 2021 | $435,000 | -29.8% | 14,926 | -5.4% | 0.00% | – |
Q1 2021 | $620,000 | +250.3% | 15,775 | +103.0% | 0.00% | – |
Q4 2020 | $177,000 | +40.5% | 7,771 | +39.6% | 0.00% | – |
Q3 2020 | $126,000 | – | 5,566 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
Grace Capital | 48,058 | $808,000 | 0.50% |
Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |